This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Innovation in medical technology exists to improve patient outcomes, increase surgical efficiency and enhance patient safety. Infrequently, we see medical technology innovation of a paradigmatic nature that changes the way physicians approach disease states and dramatically improve results.
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrialfibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the Heart Rhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. milla1cf Wed, 05/15/2024 - 19:05 May 15, 2024 — CardioFocus, Inc. ,
Titled "Real-world Data Affirms Safety and Effectiveness of Low/Zero Fluoroscopy AtrialFibrillationAblation," the study was presented as a late-breaker at the 29th Annual International AF Symposium. This is the most commonly used ablation catheter in the world for RF ablation and is fully integrated with the CARTO 3 System.
Background Cryoballoon ablation (CBA) and laser balloon ablation (LBA) are two innovative ways for the treatment of atrialfibrillation (AF). This study aimed to evaluate the efficacy and safety of cryoballoon ablation and laser balloon ablation in patients with AF.
Background Catheter ablation (CA) for symptomatic atrialfibrillation (AF) offers the best outcomes for patients. Data were collected from the MPH AF Ablation Registry with the approval of the institutional research board. We present real-world 5-year follow-up data of AI-guided pulmonary vein isolation.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heart rhythms such as atrialfibrillation (AFib).
BackgroundCatheter ablation is frequently used to manage recurrent atrialfibrillation (AF) resistant to drug therapy, with pulmonary vein isolation (PVI) as a key tactic. The reconnection of pulmonary veins was discovered primarily in the anterior region of the right superior PV and the superior portion of the left superior PV.
Medtronic Creates History with FDA Approval of its Novel PulseSelect Pulsed Field Ablation System to Treat AtrialFibrillation 3. AtrialFibrillation Market Reaches $20.92B, According to New Report 9. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study
Symptom-driven electrocardiogram (ECG) recording plays a significant role in the detection of post-ablationatrialfibrillation recurrence (AFR). The authors of an article published in Cardiovascular Innovations and Applications deployed a deep learning (DL)-based handheld device to facilitate symptom-driven monitoring.
Pulsed field ablation (PFA) is an innovative technology recently adopted for treating atrialfibrillation (AF). Preclinical and clinical studies have reported a reassuring safety profile because of its tissue-specific effect, sparing adjacent tissues.1
tim.hodson Wed, 03/12/2025 - 15:36 Broward Health recently announced it is now offering the Farapulse Pulsed Field Ablation System to treat atrialfibrillation (A-Fib). This innovative treatment represents a significant advancement over traditional thermal ablation methods and provides a more effective solution for patients.
Cryoablation (CRYO) is a novel catheter ablation technique for atrialfibrillation (AF). A study published in Cardiovascular Innovations and Applications explores whether CRYO influences the metabolic signature—a possibility not previously investigated.
An innovative mapping and ablation catheter (Sphere-9TM, Medtronic) fully integrated into a novel mapping and ablation platform (AfferaTM, Medtronic) was introduced (1,2).
a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrialfibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.
Additionally, this platform integrates parameters such as contact force measurement and ablation indexes for RF and PFA which have proven in preclinical studies to be critical for lesion creation. With this differentiated system, Biosense Webster is giving EPs the tools and information they need in real-time.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
September is National AtrialFibrillation (AFib) Awareness Month, a time dedicated to raising awareness about one of the most common yet often misunderstood heart conditions. Understanding AtrialFibrillationAtrialFibrillation is characterized by an irregular and often rapid heart rhythm that can lead to poor blood flow.
Atrialfibrillation (AF) is critically influenced by the left atrial (LA) substrate, impacting both the initiation and maintenance of AF and the outcomes of ablation treatments.
Abstract Introduction Pulsed field ablation (PFA) has emerged as an innovative technique for pulmonary vein isolation (PVI). Methods We prospectively enrolled 166 consecutive patients with paroxysmal or persistent atrialfibrillation (AF) undergoing PVI with PFA at our institution.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023 AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
As ECG Excellence we are proud our CineECG technology was part of this innovation festival. Their study focuses on the issue of localizing the origin of atrial ectopic activity. If you want to learn more go to : [link] and search for CineECG The post Origin of atrial ectopic activity appeared first on ECG-Excellence.
During its Annual Conference, HRS 2024, the Heart Rhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrialfibrillation (AF).
The collaboration, according to a written statement issued by the company, aims to address challenges in capturing and analyzing cardiac signals to help physicians enhance patient outcomes for atrialfibrillation procedures. Our mission to combat complex heart rhythm diseases relies on optimizing interoperability.
The VARIPULSE Platform is comprised of the VARIPULSE Catheter, a fully integrated variable-loop multielectrode catheter; the TRUPULSE Generator, a pulsed field ablation (PFA) generator; and the CARTO 3 System VARIPULSE Software, which provides full integration with the world's leading 3D cardiac mapping system.
Launching the first FDA -approved PFA technology is not just a milestone; the PulseSelect PFA system is setting a new standard in safety for AF ablation with excellent efficacy and efficiency 1. In my clinical experience with the catheter, it was designed for AF ablation procedures.
An international consensus statement on how to treat atrialfibrillation with catheter or surgical ablation has been published in EP Europace, a journal of the European Society of Cardiology (ESC), and was recently presented at EHRA 2024, a scientific congress held April 7-9 in Berlin, Germany.
cardiac electrophysiologist, performed one of the nations first procedures to control atrialfibrillation (Afib) using a new type of catheter that can deliver two different types of electrical energy or ablation to destroy the damaged part of the heart that is triggering the abnormal heartbeats. 12, 2025 On Feb.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrialfibrillation ( AF ) using pulsed field ablation (PFA).
milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. The Increasing Role of Rhythm Control in Patients With AtrialFibrillation.
Clinical trials and innovative technology took center stage during the month of April, racking up some record number views. Shorten the Blanking Period After AtrialFibrillationAblation, Experts Say 4. Here is a look at what DAIC viewers were reading last month: 1.
This announcement comes at a time when atrialfibrillation (AF) is on the rise, affecting more than 10.5 1 A growing patient population, increase in electrophysiology procedures, and rapid innovation in the field have led to elevated government scrutiny on cost, resulting in drastic cuts for reimbursement for common AF procedures.
Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases.
The PulseSelect Pulsed Field Ablation System, which was FDA approved in December 2023, offers physicians a safe, single-shot solution for pulmonary vein isolation (PVI) while the Affera Sphere-9 catheter enables physician treatment flexibility with its wide area focal design and 9mm lattice tip that can used with an 8.5Fr sheath.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content